# The Efficacy and Safety Assessment of Huafu Shengji Ointment in Patients With Diabetic Foot of Qi Deficiency and Blood Stasis Syndrome

> **NCT06487117** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Daxing District Hospital of Integrated Chinese and Western Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Diabetic Foot

## Interventions

- **DRUG:** Huafu Shengji Ointment
- **DRUG:** ethacridine lactate solution

## Key facts

- **NCT ID:** NCT06487117
- **Lead sponsor:** Beijing Daxing District Hospital of Integrated Chinese and Western Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06487117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06487117, "The Efficacy and Safety Assessment of Huafu Shengji Ointment in Patients With Diabetic Foot of Qi Deficiency and Blood Stasis Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06487117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*